Literature DB >> 8642887

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.

W A Hauser1, J F Annegers, W A Rocca.   

Abstract

Studies based on the Rochester Epidemiology Project medical records-linkage system have provided important insights into the epidemiology of epilepsy. The incidence of all convulsive disorders in Rochester, Minnesota, during a 50-year period exceeded 130 per 100,000 person-years. The age-adjusted incidence of epilepsy was 44 per 100,000 person-years; of a first unprovoked seizure, 61; and of acute symptomatic seizures excluding febrile convulsions, 31. In addition, 2% of the population experienced a febrile convulsion before the age of 5 years. The cumulative incidence of epilepsy through age 74 years was 3.0%, of all unprovoked seizures was 4.1%, and of any convulsive disorder approached 10%. For epilepsy, single unprovoked seizures, and acute symptomatic seizures, the incidence was significantly higher in males than in females, and it was high in the first year of life but highest in those age 75 years or older. For epilepsy alone, approximately 60% of incidence cases experienced partial seizures, and two-thirds had no clearly identified antecedent. Cerebrovascular disease was the most commonly identified antecedent of epilepsy, accounting for 11% of cases. Over time, the incidence of epilepsy and of unprovoked seizures decreased in children and increased in the elderly population. The age-adjusted prevalence of active epilepsy on Jan. 1, 1980, was 6.8 per 1,000 residents. Prevalence was low in the first decade of life, increased to a plateau in the adult years, and further increased in the elderly population. Almost 1.5% of the population older than 75 years of age had active epilepsy. About 25% of prevalence cases had an identified cause; 60% experienced partial epilepsy.

Entities:  

Mesh:

Year:  1996        PMID: 8642887     DOI: 10.4065/71.6.576

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  104 in total

1.  Neurology in practice: epilepsy.

Authors:  I Bone; G N Fuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 2.  The relationship of psychiatric illnesses and seizures.

Authors:  N D Tsopelas; R Saintfort; G L Fricchione
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

3.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

4.  From bench to bedside: unique challenges of treating epilepsy in the aging brain.

Authors:  Lee A Shapiro
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

5.  Automatic seizure detection in SEEG using high frequency activities in wavelet domain.

Authors:  L Ayoubian; H Lacoma; J Gotman
Journal:  Med Eng Phys       Date:  2012-05-29       Impact factor: 2.242

6.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

Review 7.  [Clinical features, diagnosis, and treatment of dysphoric states and psychoses associated with epilepsy].

Authors:  H-B Rothenhäusler
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

8.  Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.

Authors:  Hyunmi Kim; Edward Faught; David J Thurman; Jesse Fishman; Linda Kalilani
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

Review 9.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

10.  Familial risk of epilepsy: a population-based study.

Authors:  Anna L Peljto; Christie Barker-Cummings; Vincent M Vasoli; Cynthia L Leibson; W Allen Hauser; Jeffrey R Buchhalter; Ruth Ottman
Journal:  Brain       Date:  2014-01-26       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.